Table 3.
WHO Criteria | MoHFW Criteria | |
---|---|---|
Thyroid stimulating hormone (mIU/L) | ||
Asymptomatic | 3.4±4.4 (2.5-4.2) | 3.4±4.4 (2.5-4.2) |
Mild | 4.7±11.4 (2.0-7.5) | 4.7±11.4 (2.0-7.5) |
Moderate | 2.8±2.0 (1.9-3.6) | 2.8±2.0 (1.9-3.6) |
Severe | 2.0±1.4 (1.3-2.6) | 2.1±2.3 (1.2-2.9) |
Critical | 2.3±3.7 (-0.3-4.9) | - |
P* | 0.004 | 0.002 |
Free thyroxin (pmol/L) | ||
Asymptomatic | 14.2±3.9 (12.9-14.2) | 14.2±3.9 (12.9-14.2) |
Mild | 14.2±2.6 (14.2-15.4) | 14.2±2.6 (14.2-15.4) |
Moderate | 16.7±5.1 (14.2-18.0) | 16.7±5.1 (14.2-18.0) |
Severe | 15.4±2.6 (14.2-16.7) | 15.4±3.9 (12.9-16.7) |
Critical | 15.4±5.1 (11.6-20.6) | - |
P* | 0.003 | 0.002 |
Free tri-iodothyronine (pmol/L) | ||
Asymptomatic | 4.0±0.9 (3.8-4.1) | 4.0±0.9 (3.8-4.1) |
Mild | 4.0±0.8 (3.7-4.1) | 4.0±0.8 (3.7-4.1) |
Moderate | 3.4±0.8 (3.1-3.7) | 3.4±0.8 (3.1-3.7) |
Severe | 3.1±0.8 (2.8-3.4) | 2.9±1.1 (2.6-3.4) |
Critical | 2.8±1.4 (1.7-3.8) | - |
P* | <0.0001 | <0.0001 |
Krushal Wallis test. WHO-World Health Organization, MoHFW- Ministry of Health & Family Welfare